ANGN Annual CFO
-$38.39 M
+$14.25 M+27.07%
31 December 2022
Summary:
As of February 5, 2025, ANGN annual cash flow from operations is -$38.39 million, with the most recent change of +$14.25 million (+27.07%) on December 31, 2022. During the last 3 years, it has fallen by -$13.80 million (-56.13%).ANGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANGN Quarterly CFO
-$8.08 M
-$3.65 M-82.54%
31 March 2023
Summary:
As of February 5, 2025, ANGN quarterly cash flow from operations is -$8.08 million, with the most recent change of -$3.65 million (-82.54%) on March 31, 2023. Over the past year, it has increased by +$7.57 million (+48.39%).ANGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANGN TTM CFO
-$30.82 M
+$7.57 M+19.73%
31 March 2023
Summary:
As of February 5, 2025, ANGN TTM cash flow from operations is -$30.82 million, with the most recent change of +$7.57 million (+19.73%) on March 31, 2023. Over the past year, it has increased by +$24.93 million (+44.72%).ANGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANGN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.1% | +48.4% | +44.7% |
| 3 y3 years | -56.1% | +7.5% | -252.9% |
| 5 y5 years | -378.7% | - | - |
ANGN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -2128.7% | -139.2% | -1629.9% |
Angion Biomedica Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$8.08 M(+82.5%) | -$30.82 M(-19.7%) |
| Dec 2022 | -$38.39 M(-27.1%) | -$4.43 M(-47.3%) | -$38.39 M(-20.6%) |
| Sept 2022 | - | -$8.41 M(-15.1%) | -$48.33 M(-12.3%) |
| June 2022 | - | -$9.90 M(-36.7%) | -$55.12 M(-1.1%) |
| Mar 2022 | - | -$15.65 M(+9.0%) | -$55.74 M(+5.9%) |
| Dec 2021 | -$52.64 M(+130.0%) | -$14.36 M(-5.5%) | -$52.64 M(+197.6%) |
| Sept 2021 | - | -$15.20 M(+44.3%) | -$17.69 M(-27.6%) |
| June 2021 | - | -$10.53 M(-16.1%) | -$24.43 M(-8.5%) |
| Mar 2021 | - | -$12.55 M(-161.0%) | -$26.71 M(+16.7%) |
| Dec 2020 | -$22.89 M | $20.59 M(-193.8%) | -$22.89 M(-47.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$21.94 M(+71.4%) | -$43.48 M(+101.9%) |
| June 2020 | - | -$12.80 M(+46.6%) | -$21.54 M(+146.6%) |
| Mar 2020 | - | -$8.73 M(-2533.3%) | -$8.73 M(-1022.9%) |
| Dec 2019 | -$24.59 M(+206.6%) | - | - |
| Dec 2018 | -$8.02 M(-523.8%) | - | - |
| June 2014 | - | $358.90 K(-38.9%) | $946.30 K(-53.0%) |
| Mar 2014 | - | $587.40 K(-58.8%) | $2.01 M(+23.1%) |
| Dec 2013 | $1.89 M(+77.6%) | - | - |
| June 2013 | - | $1.43 M(+580.1%) | $1.64 M(+680.1%) |
| Mar 2013 | - | $209.80 K | $209.80 K |
| Dec 2012 | $1.07 M | - | - |
FAQ
- What is Angion Biomedica annual cash flow from operations?
- What is the all time high annual CFO for Angion Biomedica?
- What is Angion Biomedica annual CFO year-on-year change?
- What is Angion Biomedica quarterly cash flow from operations?
- What is the all time high quarterly CFO for Angion Biomedica?
- What is Angion Biomedica quarterly CFO year-on-year change?
- What is Angion Biomedica TTM cash flow from operations?
- What is the all time high TTM CFO for Angion Biomedica?
- What is Angion Biomedica TTM CFO year-on-year change?
What is Angion Biomedica annual cash flow from operations?
The current annual CFO of ANGN is -$38.39 M
What is the all time high annual CFO for Angion Biomedica?
Angion Biomedica all-time high annual cash flow from operations is $1.89 M
What is Angion Biomedica annual CFO year-on-year change?
Over the past year, ANGN annual cash flow from operations has changed by +$14.25 M (+27.07%)
What is Angion Biomedica quarterly cash flow from operations?
The current quarterly CFO of ANGN is -$8.08 M
What is the all time high quarterly CFO for Angion Biomedica?
Angion Biomedica all-time high quarterly cash flow from operations is $20.59 M
What is Angion Biomedica quarterly CFO year-on-year change?
Over the past year, ANGN quarterly cash flow from operations has changed by +$7.57 M (+48.39%)
What is Angion Biomedica TTM cash flow from operations?
The current TTM CFO of ANGN is -$30.82 M
What is the all time high TTM CFO for Angion Biomedica?
Angion Biomedica all-time high TTM cash flow from operations is $2.01 M
What is Angion Biomedica TTM CFO year-on-year change?
Over the past year, ANGN TTM cash flow from operations has changed by +$24.93 M (+44.72%)